Today on DrugResearcher.com   Take off immune system brake to improve cancer vaccines Mr Gene designs and orders constructs in minutes New research offers CRO market snapshot Merck, Vertex halt aurora kinase cancer trial Drugs moving into the clinic: 36

Related Industry News   Boehringer Ingelheim takes on prefilled syringes FMC improves on existing excipients Pharmaceutical patent round-up Recipharm rescues Ashton Pharma

Breaking News on Drug Discovery
Daily  Thursday 22 November 2007		Forward to a colleague

	Sponsored Link ClonePix FL - explore cell surfaces discover stellar clones ClonePix FL technology makes light-work of selecting and isolating mammalian cell clones by cell surface protein expression, rapidly yielding monoclonal populations for cell based assays, screening, downstream phenotyping/genotyping and basic discovery research... Click Here Access Full Stories Take off immune system brake to improve cancer vaccines The discovery of a new molecule that can act as a brake for the immune system could lead to new therapies for cancer and autoimmune diseases such as diabetes... Read Mr Gene designs and orders constructs in minutes Geneart has launched the first fully on-line gene construct design and ordering system, dubbed Mr Gene, which is targeting the emerging 'low-price' segment of the synthetic biology market... Read New research offers CRO market snapshot New research from Frost & Sullivan provides a snapshot of biopharma spending trends on contract research organisations (CROs), along with forecasts for industry growth... Read Merck, Vertex halt aurora kinase cancer trial Merck & Co. and its partner Vertex Pharmaceuticals have stopped enrolling cancer patients to the clinical trial of its aurora kinase trial after one patient suffered heart problems... Read Drugs moving into the clinic: 36 The latest in a series of periodic roundups of drugs that have moved from preclinical research into clinical testing via the announcement of a Phase I trial or an application for a trial to industry regulators... Read
	All News Headlines for: November | October | September
	Product Presentation ZIC®-HILIC Separation of Polar and Hydrophilic Compounds The technology leading ZIC®HILIC and ZIC®-pHILIC separation media, designed for polar and hydrophilic compounds, are tools for clinical analysis and to solve separation and purification problems in research, development and production of pharmaceuticals. ZIC®-HILIC... Click Here
	Related Industry News Boehringer Ingelheim takes on prefilled syringes Boehringer Ingelheim has added to its contract services with the manufacture, fill and finish capacity for drugs in prefilled syringes... Read FMC improves on existing excipients FMC BioPolymer has introduced two new excipient products to the pharma market - the first in two years... Read Pharmaceutical patent round-up In-PharmaTechnologist.com brings you an update of pharmaceutical patent litigations... Read Recipharm rescues Ashton Pharma Recipharm has come to rescue of UK-based Ashton Pharma, which has been nervously awaiting to discover its fate, having spent five months in administration after its former owners Inyx Inc. suffered major financial... Read Weekly Comment FDA failure on foreign inspections frightening A US government audit has confirmed the Food and Drug Administration's (FDA's) continual lack of inspection of foreign drug manufacturing plants. Read Sponsored Link DOSE IT - For easy dispensing of media and buffers Finally a programmable peristaltic pump with easy on-screen instructions and self-explanatory operation! If you are tired of complex pump operation, watch the DOSE IT online video or download the product information on the INTEGRA Biosciences website... Click Here Previous Headlines Evolution study finds 300 new genes A supercomputer designed to root out genes that have been conserved over millions of years of evolution has discovered 300 new human genes... Read Cisbio licenses 'universal' kinase assay platform Cisbio has licensed BellBrook Labs' ADP immunodetection technology for use in its HTRF screening system that will enable researchers to study the activity of any protein kinase... Read Men get the heads up on possible oral contraceptive It might be years away yet, but men could be the ones popping a pill for contraception if GTx has anything to do with it... Read No embryo required: human stem cells from the skin A startling breakthrough has allowed scientists to create human stem cells from just reprogrammed skin cells, with no embryo and thus, perhaps no ethical dilemma... Read Cancer antibody marches on quoths Raven Biotechnologies Raven Biotechnologies have announced positive initial clinical trial results for their anticancer antibody that causes tumour cells to swell up and die... Read Technical / White Papers, Case studies, Web casts Benefits of integrating human tissue research in drug discovery - Technical / White Paper Product Information - brochures, Web centers DAICEL chiral chromatography products - Company Profile Product Innovation Alerts - Free of Charge Indicate your research interests and receive alerts on relevant products and market innovations Analysis and instrumentation Assays and screening Cell culture & Equipment Chromatography Compounds and consumables Contract services (outsourcing) Drug discovery Genomics / Proteomics Informatics & IT Lab equipment & consumables Liquid handling and automation Liquid handling and sample preparation Production technologies Separation and purification

	Free Newsletters for Pharmaceuticals Access now !Choose from over 20 industry e-newsletters Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here
	Forward to a colleague

	To continue to receive this newsletter in your inbox, please add newsletter@DrugResearcher.com to your address book
	Update preferences | Change your email address | Unsubscribe
	Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback
	© 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com